sözaltı news Finance
Finance
EN AZ
FDA advisers are reviewing a multicancer-detection test. Medicare coverage could follow.

FDA advisers are reviewing a multicancer-detection test. Medicare coverage could follow.

marketwatch.com 23.09.2026 14:39 6 views
Grail’s Galleri test looks for 50 cancers from a blood draw, but a major study failed to prove it could detect later-stage cancers.